{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:26:56Z","timestamp":1787570816749,"version":"build-2736575974"},"reference-count":89,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>Depression is a highly prevalent and clinically significant comorbidity in Crohn\u2019s disease (CD), a form of inflammatory bowel disease (IBD), and is associated with increased disease activity, hospitalization, and a reduced quality of life (QoL). While traditionally attributed to the psychosocial burden of chronic illness, emerging evidence indicates that depressive symptoms in CD arise from dysregulation of the gut-brain axis (GBA), a bidirectional network linking immune, microbial, and central nervous system (CNS) processes. Chronic intestinal inflammation, characterized by elevated cytokines such as tumor necrosis factor (TNF-\u03b1) and interleukin-6 (IL-6), may influence brain function through vagal signaling, hypothalamic-pituitary-adrenal (HPA) axis activation, and neuroimmune pathways. Concurrently, epithelial barrier dysfunction and microbial dysbiosis promote translocation of bacterial products, further amplifying systemic inflammation and neuroimmune signaling. This review consolidates preclinical and clinical evidence linking immune activation, microbial alterations, and neuroimmune signaling to depression in CD. The review compares emerging therapeutic strategies, such as ketamine enantiomers, vagus nerve stimulation, and microbiota-targeting natural compounds, with established therapies like serotonergic antidepressants, cognitive behavioral therapy, and biologic immunotherapies. Across these modalities, therapeutic effects on mood are heterogeneous and often dissociated from improvements in intestinal inflammation, highlighting the multifunctional nature of GBA dysfunction. Overall, these findings suggest that therapeutic responses in CD-associated depression may depend on the extent to which interventions modulate distinct components of the GBA, including immune, neural, and microbial pathways. These observations emphasize the need for integrative treatment strategies that address the multiple contributors of GBA dysbiosis. Future studies incorporating standardized and emerging psychiatric, immunological, and microbiome outcomes will be critical to identifying mechanisms for specific treatment responses in this population.<\/jats:p>","DOI":"10.3389\/fnins.2026.1920926","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:09:53Z","timestamp":1787569793000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Bridging the gut and mind: a narrative review of depression in Crohn\u2019s disease and emerging gut-brain axis therapies"],"prefix":"10.3389","volume":"20","author":[{"given":"Zo\u00eb","family":"Pipa","sequence":"first","affiliation":[{"name":"Department of Pharmacology & Physiology, Georgetown University","place":["Washington, DC, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Newton","family":"Howard","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Physiology, Georgetown University","place":["Washington, DC, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/01.meg.0000108344.41221.8b","article-title":"Increased production of granulocyte-macrophage colony-stimulating factor in Crohn\u2019s disease\u2013a possible target for infliximab treatment.","volume":"16","author":"Agnholt","year":"2004","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/apt.12195","article-title":"Psychiatric co-morbidity is associated with increased risk of surgery in Crohn\u2019s disease.","volume":"37","author":"Ananthakrishnan","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B3","doi-asserted-by":"publisher","first-page":"721","DOI":"10.5152\/tjg.2020.19554","article-title":"Does serotonin in the intestines make you happy?","volume":"31","author":"Bekta\u015f","year":"2020","journal-title":"Turk. J. Gastroenterol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1111\/j.1365-2982.2011.01796.x","article-title":"The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication.","volume":"23","author":"Bercik","year":"2011","journal-title":"Neurogastroenterol. Motil."},{"key":"B5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0092-8674(93)90305-a","article-title":"Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1.","volume":"74","author":"Berlin","year":"1993","journal-title":"Cell"},{"key":"B6","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/s0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients.","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"B7","doi-asserted-by":"publisher","first-page":"R200","DOI":"10.1152\/ajpregu.1991.260.1.R200","article-title":"Topography of efferent vagal innervation of the rat gastrointestinal tract.","volume":"260","author":"Berthoud","year":"1991","journal-title":"Am. J. Physiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1089\/ars.2012.4530","article-title":"Inflammatory bowel disease: Mechanisms, redox considerations, and therapeutic targets.","volume":"19","author":"Biasi","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"B9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fnins.2018.00049","article-title":"The vagus nerve at the interface of the microbiota-gut-brain axis.","volume":"12","author":"Bonaz","year":"2018","journal-title":"Front. Neurosci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.3389\/fimmu.2017.01452","article-title":"The vagus nerve in the neuro-immune axis: Implications in the pathology of the gastrointestinal tract.","volume":"8","author":"Bonaz","year":"2017","journal-title":"Front. Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/35013070","article-title":"Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin.","volume":"405","author":"Borovikova","year":"2000","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e00579","DOI":"10.14309\/ctg.0000000000000579","article-title":"Clinical value of multiomics-based biomarker signatures in inflammatory bowel diseases: Challenges and opportunities.","volume":"14","author":"Bourgonje","year":"2023","journal-title":"Clin. Transl. Gastroenterol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e87785","DOI":"10.1371\/journal.pone.0087785","article-title":"Neuro-anatomical evidence indicating indirect modulation of macrophages by vagal efferents in the intestine but not in the spleen.","volume":"9","author":"Cailotto","year":"2014","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.62347\/XILL3707","article-title":"Artificial intelligence use for precision medicine in inflammatory bowel disease: A systematic review.","volume":"17","author":"Ceccato","year":"2025","journal-title":"Am. J. Transl. Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bcp.2017.09.008","article-title":"Free-fatty acid receptor-4 (FFA4) modulates ROS generation and COX-2 expression via the C-terminal \u03b2-arrestin phosphosensor in Raw 264.7 macrophages.","volume":"146","author":"Cheshmehkani","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1007\/s00429-021-02322-8","article-title":"Distribution of two isoforms of tryptophan hydroxylase in the brain of rainbow trout (Oncorhynchus mykiss). An in situ hybridization study.","volume":"226","author":"Chivite","year":"2021","journal-title":"Brain Struct. Funct."},{"key":"B17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.imlet.2014.04.004","article-title":"Inflammatory bowel disease.","volume":"161","author":"Corridoni","year":"2014","journal-title":"Immunol. Lett."},{"key":"B18","doi-asserted-by":"publisher","first-page":"13525","DOI":"10.1073\/pnas.2233056100","article-title":"Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function.","volume":"100","author":"C\u00f4t\u00e9","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1007\/s00213-018-5006-5","article-title":"Differential effects of psychotropic drugs on microbiome composition and gastrointestinal function.","volume":"236","author":"Cussotto","year":"2019","journal-title":"Psychopharmacology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"5522","DOI":"10.3390\/jcm14155522","article-title":"Interplay between depression and inflammatory bowel disease: Shared pathogenetic mechanisms and reciprocal therapeutic impacts-A comprehensive review.","volume":"14","author":"Di Petrillo","year":"2025","journal-title":"J. Clin. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.23736\/S2724-5985.24.03719-7","article-title":"Monitoring the psychopathological profile of inflammatory bowel disease patients treated with biological agents: A pilot study.","volume":"71","author":"D\u2019Onofrio","year":"2025","journal-title":"Minerva Gastroenterol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1080\/17474124.2021.1911644","article-title":"Burden of comorbid anxiety and depression in patients with inflammatory bowel disease: A systematic literature review.","volume":"15","author":"Dubinsky","year":"2021","journal-title":"Expert. Rev. Gastroenterol. Hepatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"G989","DOI":"10.1152\/ajpgi.00086.2016","article-title":"Modulation of the microbiota-gut-brain axis by probiotics in a murine model of inflammatory bowel disease.","volume":"310","author":"Emge","year":"2016","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1215739","article-title":"Vedolizumab as induction and maintenance therapy for Crohn\u2019s disease.","volume":"369","author":"Feagan","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/0361-9230(95)00051-f","article-title":"Interleukin-1 beta induced corticosterone elevation and hypothalamic NE depletion is vagally mediated.","volume":"37","author":"Fleshner","year":"1995","journal-title":"Brain Res. Bull."},{"key":"B26","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrgastro.2012.156","article-title":"The role of the gut microbiota in nutrition and health.","volume":"9","author":"Flint","year":"2012","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1136\/gutjnl-2018-317182","article-title":"Depression increases the risk of inflammatory bowel disease, which may be mitigated by the use of antidepressants in the treatment of depression.","volume":"68","author":"Frolkis","year":"2018","journal-title":"Gut"},{"key":"B28","doi-asserted-by":"publisher","first-page":"173954","DOI":"10.1016\/j.ejphar.2021.173954","article-title":"Dextran sulfate sodium-induced inflammation and colitis in mice are ameliorated by (R)-ketamine, but not (S)-ketamine: A role of TrkB signaling.","volume":"897","author":"Fujita","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/00054725-200608000-00005","article-title":"Depression and inflammatory bowel disease: Findings from two nationally representative Canadian surveys.","volume":"12","author":"Fuller-Thomson","year":"2006","journal-title":"Inflamm. Bowel Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41398-023-02670-5","article-title":"Gut microbiota composition in depressive disorder: A systematic review, meta-analysis, and meta-regression.","volume":"13","author":"Gao","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"B31","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/ecco-jcc\/jjz195","article-title":"Predictors of primary response to biologic treatment [Anti-TNF, Vedolizumab, and Ustekinumab] in patients with inflammatory bowel disease: From basic science to clinical practice.","volume":"14","author":"Gisbert","year":"2020","journal-title":"J. Crohn\u2019s Colitis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/ecco-jcc\/jjw168","article-title":"3rd European evidence-based consensus on the diagnosis and management of Crohn\u2019s disease 2016: Part 1: Diagnosis and medical management.","volume":"11","author":"Gomoll\u00f3n","year":"2017","journal-title":"J. Crohns Colitis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1053\/j.gastro.2018.01.027","article-title":"Bi-directionality of brain-gut interactions in patients with inflammatory bowel disease.","volume":"154","author":"Gracie","year":"2018","journal-title":"Gastroenterology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/ibd.20873","article-title":"Depression and anxiety in inflammatory bowel disease: A review of comorbidity and management.","volume":"15","author":"Graff","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.14309\/ajg.0000000000002800","article-title":"Central neuromodulators in irritable bowel syndrome: Why, how, and when.","volume":"119","author":"Hanna-Jairala","year":"2024","journal-title":"Am. J. Gastroenterol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/pcn.12902","article-title":"Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.","volume":"73","author":"Hashimoto","year":"2019","journal-title":"Psychiatry Clin. Neurosci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"980189","DOI":"10.3389\/fimmu.2022.980189","article-title":"Selective serotonin reuptake inhibitors and inflammatory bowel disease; Beneficial or malpractice.","volume":"13","author":"Hatamnejad","year":"2022","journal-title":"Front Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41392-022-00974-4","article-title":"Microbiota in health and diseases.","volume":"7","author":"Hou","year":"2022","journal-title":"Signal Transduct Target Ther."},{"key":"B39","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s10880-019-09621-7","article-title":"Self-help cognitive behavioral therapy improves health-related quality of life for inflammatory bowel disease patients: A randomized controlled effectiveness trial.","volume":"27","author":"Hunt","year":"2020","journal-title":"J. Clin. Psychol. Med. Settings"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.3389\/fimmu.2018.01212","article-title":"Effector T helper cell subsets in inflammatory bowel diseases.","volume":"9","author":"Imam","year":"2018","journal-title":"Front. Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1111\/apt.16820","article-title":"Antidepressant medication use in inflammatory bowel disease: A nationally representative population-based study.","volume":"55","author":"Jayasooriya","year":"2022","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1021\/acsptsci.3c00123","article-title":"Transient elevation of plasma glucocorticoids supports psilocybin-induced anxiolysis in mice.","volume":"6","author":"Jones","year":"2023","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1111\/j.1572-0241.1999.01220.x","article-title":"Type 1 T-helper cell predominance in granulomas of Crohn\u2019s disease.","volume":"94","author":"Kakazu","year":"1999","journal-title":"Am. J. Gastroenterol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","article-title":"TNF biology, pathogenic mechanisms and emerging therapeutic strategies.","volume":"12","author":"Kalliolias","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1017\/S0033291716000064","article-title":"Single-dose infusion ketamine and non-ketamine N-methyl-D-aspartate receptor antagonists for unipolar and bipolar depression: A meta-analysis of efficacy, safety and time trajectories.","volume":"46","author":"Kishimoto","year":"2016","journal-title":"Psychol. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.chom.2020.05.004","article-title":"The serotonin neurotransmitter modulates virulence of enteric pathogens.","volume":"28","author":"Kumar","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B47","doi-asserted-by":"publisher","first-page":"117175","DOI":"10.1016\/j.taap.2024.117175","article-title":"Curcumin alleviated dextran sulfate sodium-induced ulcerative colitis via inhibition of the Wnt\/\u03b2-catenin signaling pathway and regulation of the differentiation of intestinal stem cells.","volume":"494","author":"Liang","year":"2025","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ajg.2018.27","article-title":"ACG Clinical guideline: Management of Crohn\u2019s disease in adults.","volume":"113","author":"Lichtenstein","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nri3024","article-title":"Neutrophils in the activation and regulation of innate and adaptive immunity.","volume":"11","author":"Mantovani","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1136\/gutjnl-2012-302550","article-title":"The vagal innervation of the gut and immune homeostasis.","volume":"62","author":"Matteoli","year":"2013","journal-title":"Gut"},{"key":"B51","doi-asserted-by":"publisher","first-page":"105926","DOI":"10.1016\/j.nbd.2022.105926","article-title":"Blood brain barrier and inflammation in depression.","volume":"175","author":"Medina-Rodriguez","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1038\/s41593-017-0010-3","article-title":"Social stress induces neurovascular pathology promoting depression.","volume":"20","author":"Menard","year":"2017","journal-title":"Nat. Neurosci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/ar.1092130111","article-title":"Macrophage-like cells in the muscularis externa of mouse small intestine.","volume":"213","author":"Mikkelsen","year":"1985","journal-title":"Anat. Rec."},{"key":"B54","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cgh.2015.12.045","article-title":"Symptoms of depression and anxiety are independently associated with clinical recurrence of inflammatory bowel disease.","volume":"14","author":"Mikocka-Walus","year":"2016","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.biopsych.2012.06.022","article-title":"Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression.","volume":"74","author":"Murrough","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3390\/plants9091127","article-title":"Phytochemical, cytotoxicity, antioxidant and anti-inflammatory effects of psilocybe natalensis magic mushroom.","volume":"9","author":"Nkadimeng","year":"2020","journal-title":"Plants"},{"key":"B57","doi-asserted-by":"publisher","first-page":"101266","DOI":"10.3748\/wjg.v31.i6.101266","article-title":"Gut microbiota in Crohn\u2019s disease pathogenesis.","volume":"31","author":"Ozbey","year":"2025","journal-title":"World J. Gastroenterol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1136\/gutjnl-2020-322260","article-title":"Mucus barrier, mucins and gut microbiota: The expected slimy partners?","volume":"69","author":"Paone","year":"2020","journal-title":"Gut"},{"key":"B59","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/bf03402177","article-title":"The cholinergic anti-inflammatory pathway: A missing link in neuroimmunomodulation.","volume":"9","author":"Pavlov","year":"2003","journal-title":"Mol. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1055\/s-0034-1391855","article-title":"Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline.","volume":"47","author":"Pennazio","year":"2015","journal-title":"Endoscopy"},{"key":"B61","doi-asserted-by":"publisher","first-page":"G327","DOI":"10.1152\/ajpgi.00422.2010","article-title":"Importance and regulation of the colonic mucus barrier in a mouse model of colitis.","volume":"300","author":"Petersson","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/BF00198950","article-title":"The fiber composition of the abdominal vagus of the rat.","volume":"181","author":"Prechtl","year":"1990","journal-title":"Anat. Embryol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.3390\/life13122345","article-title":"Psilocybin and eugenol reduce inflammation in human 3D Epiintestinal tissue.","volume":"13","author":"Robinson","year":"2023","journal-title":"Life"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1111\/nmo.12373","article-title":"The link between negative affect, vagal tone, and visceral sensitivity in quiescent Crohn\u2019s disease.","volume":"26","author":"Rubio","year":"2014","journal-title":"Neurogastroenterol. Motil."},{"key":"B65","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1111\/bcp.15261","article-title":"Higher anticholinergic burden from medications is associated with significant increase in markers of inflammation in the EPIC-Norfolk prospective population-based cohort study.","volume":"88","author":"Sanghavi","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"G391","DOI":"10.1152\/ajpgi.1999.277.2.G391","article-title":"Corticotropin-releasing hormone mimics stress-induced colonic epithelial pathophysiology in the rat.","volume":"277","author":"Santos","year":"1999","journal-title":"Am. J. Physiol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s40364-025-00802-1","article-title":"Microbiome multi-omics analysis reveals novel biomarkers and mechanisms linked with CD etiopathology.","volume":"13","author":"Serrano-G\u00f3mez","year":"2025","journal-title":"Biomark Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/gene.2015.47","article-title":"Multifaceted role of \u03b2-arrestins in inflammation and disease.","volume":"16","author":"Sharma","year":"2015","journal-title":"Genes Immun."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e13911","DOI":"10.1111\/nmo.13911","article-title":"A 12-month pilot study outcomes of vagus nerve stimulation in Crohn\u2019s disease.","volume":"32","author":"Sinniger","year":"2020","journal-title":"Neurogastroenterol. Motil."},{"key":"B70","doi-asserted-by":"publisher","first-page":"682868","DOI":"10.3389\/fpsyt.2021.682868","article-title":"Serotonin reuptake inhibitors and the gut microbiome: Significance of the gut microbiome in relation to mechanism of action, treatment response, side effects, and tachyphylaxis.","volume":"12","author":"Sj\u00f6stedt","year":"2021","journal-title":"Front. Psychiatry"},{"key":"B71","first-page":"1","article-title":"Vedolizumab in inflammatory bowel disease: A review of mechanism of action, efficacy, and safety.","volume":"12","author":"Solomon","year":"2019","journal-title":"Ther. Adv. Gastroenterol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1210\/jcem.83.5.4795","article-title":"Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men.","volume":"83","author":"Sp\u00e4th-Schwalbe","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B73","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10620-016-4356-2","article-title":"Vedolizumab therapy is associated with an improvement in sleep quality and mood in inflammatory bowel diseases.","volume":"62","author":"Stevens","year":"2017","journal-title":"Dig. Dis. Sci."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/apt.12749","article-title":"Systematic review with network meta-analysis: The efficacy of anti-TNF agents for the treatment of Crohn\u2019s disease.","volume":"39","author":"Stidham","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B75","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1038\/npp.2017.94","article-title":"Dose-related effects of adjunctive ketamine in taiwanese patients with treatment-resistant depression.","volume":"42","author":"Su","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1136\/gut.50.2.206","article-title":"Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn\u2019s disease.","volume":"50","author":"ten Hove","year":"2002","journal-title":"Gut"},{"key":"B77","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.euroneuro.2013.12.006","article-title":"Psilocybin\u2013summary of knowledge and new perspectives.","volume":"24","author":"Tyl\u0161","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2016.03.010","article-title":"The blood-brain barrier in systemic inflammation.","volume":"60","author":"Varatharaj","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"B79","first-page":"661","article-title":"Crohn\u2019s disease: Diagnosis and management.","volume":"98","author":"Veauthier","year":"2018","journal-title":"Am. Fam. Phys."},{"key":"B80","doi-asserted-by":"publisher","first-page":"114653","DOI":"10.1016\/j.bbr.2023.114653","article-title":"Effects of cognitive behavioral therapy on mental health and quality of life in inflammatory bowel disease patients: A meta-analysis of randomized controlled trials.","volume":"454","author":"Wang","year":"2023","journal-title":"Behav. Brain Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature01339","article-title":"Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation.","volume":"421","author":"Wang","year":"2003","journal-title":"Nature"},{"key":"B82","doi-asserted-by":"publisher","first-page":"105635","DOI":"10.1016\/j.nbd.2022.105635","article-title":"(R)-ketamine ameliorates demyelination and facilitates remyelination in cuprizone-treated mice: A role of gut-microbiota-brain axis.","volume":"165","author":"Wang","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"B83","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1097\/MEG.0000000000002768","article-title":"Antidepressant treatment in inflammatory bowel disease: A systematic review and meta-analysis.","volume":"36","author":"Weston","year":"2024","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.3390\/microorganisms8101587","article-title":"Gut microbiota and immune system interactions.","volume":"8","author":"Yoo","year":"2020","journal-title":"Microorganisms"},{"key":"B85","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1097\/HJH.0000000000002517","article-title":"Anxiety, depression, chronic inflammation and aortic stiffness in Crohn\u2019s disease: The brain\u2013gut\u2013vascular axis.","volume":"38","author":"Zanoli","year":"2020","journal-title":"J. Hypertens"},{"key":"B86","doi-asserted-by":"publisher","first-page":"106563","DOI":"10.1016\/j.fitote.2025.106563","article-title":"Combating depression with rosemary (Rosmarinus officinalis L.)-derived polyphenols: Major phytochemicals, functional properties, and potential.","volume":"183","author":"Zhang","year":"2025","journal-title":"Fitoterapia"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.3390\/jcm12031152","article-title":"Intraoperative low-dose S-Ketamine reduces depressive symptoms in patients with Crohn\u2019s disease undergoing bowel resection: A randomized controlled trial.","volume":"12","author":"Zhang","year":"2023","journal-title":"J. Clin. Med."},{"key":"B88","doi-asserted-by":"publisher","first-page":"102574","DOI":"10.1016\/j.xcrm.2025.102574","article-title":"Microbiota-metabolome interplay in depression: Metabolic insights and diagnostic potential.","volume":"7","author":"Zhao","year":"2026","journal-title":"Cell. Rep. Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"116214","DOI":"10.1016\/j.foodres.2025.116214","article-title":"Jasmine tea extract prevents CUMS-induced depression-like behaviors through the modulation of microbiota-gut-brain axis.","volume":"209","author":"Zhou","year":"2025","journal-title":"Food Res. Int."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2026.1920926\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:09:54Z","timestamp":1787569794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2026.1920926\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":89,"alternative-id":["10.3389\/fnins.2026.1920926"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2026.1920926","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"article-number":"1920926"}}